Audio By Carbonatix
The Nigerian authorities say trials are due to begin to see whether an anti-malarial drug is effective against coronavirus.
The commissioner for health in Lagos state said healthcare workers as well as people in close contact with someone with the virus would be either given chloroquine or a placebo.
A second trial is to be launched in partnership with the World Health Organization (WHO).
Officials say results should be known within two months.
US President Donald Trump caused controversy earlier this week when he told reporters he had been taking another anti-malarial drug - hydroxychloroquine - despite warnings it might be unsafe.
While the trials are taking place in a controlled clinical environment, the WHO has warned that some individuals are self-medicating and risk causing themselves serious harm.
Chloroquine has not yet been shown to be safe and effective in the prevention or treatment of coronavirus and can cause dangerous heart arrhythmias.
Lagos Health Commissioner Prof Akin Abayomi also said the government was trying to transition to home-based isolation, admitting that some patients who tested positive for the virus were absconding and reluctant to be admitted to isolation units.
Latest Stories
-
ECG to cut power in parts of Accra West on February 11 for planned maintenance
2 hours -
BoG announces guidelines to govern foreign exchange spot interventions
3 hours -
Intelligence report uncovers weapons transfers under Sudanese Army oversight to South Kordofan
3 hours -
119 people died during mediation efforts in Bawku conflict – Mahama
3 hours -
Trade Ministry to lead raw material expansion for 24-hour production, youth jobs & exports
3 hours -
Migration induced by coastal erosion: The Shama experience
3 hours -
Ghana’s economy to expand by 5.67% in 2026
3 hours -
A/R: ECG surcharges over 2,200 customers for illegal connections, recovers over GH¢4.3bn in 2025
3 hours -
With galamsey still ongoing, who is buying the gold? – Oppong Nkrumah questions gov’t
3 hours -
Avoiding Fiscal Risks in GCR’s deal with GoldBod
3 hours -
Suame Interchange won’t affect NPP votes in Ashanti – Asenso-Boakye
4 hours -
Mahama receives Transition Committee report on UGMC transfer to University of Ghana
4 hours -
Quiz Talk National STEM Programme instituted to boost innovation in basic schools
4 hours -
Unemployed graduates with disabilities engage Gender Minister on jobs and inclusion
4 hours -
Parliament approves GH¢2.9bn for Ghana Medical Trust Fund
4 hours
